George J Atiee MD

Family Medicine•San Antonio, TX

Physician

Join to View Full Profile

2108 NW Military HwySan Antonio, TX 78213
Phone+1 210-342-7300
Fax+1 210-635-1646

Education & Training

Baylor College of MedicineResidency, Family Medicine, 1985 - 1988
The University of Texas Health Science Center at San AntonioClass of 1985

Certifications & Licensure

NE State Medical License 2010 - 2026
IN State Medical License 1998 - 2025
KS State Medical License 2022 - 2025
TX State Medical License 1986 - 2025

Clinical Trials

Safety of ALK Ragweed Tablet Start of enrollment: 2006 May 01
Completed
Phase 1
Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza. Start of enrollment: 2007 Jan 01
Completed
Phase 2
Safety, Reactogenicity and Immunogenicity of an H5N1 VLP Start of enrollment: 2007 Jul 01
Completed
Phase 1, Phase 2
Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions Start of enrollment: 2014 Jan 01
Completed
Not Applicable
Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers Start of enrollment: 2016 Jan 01
Completed
Phase 1
Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study Start of enrollment: 2018 Oct 16
Completed
Early Phase 1
A Safety Study of PTI-125 in Healthy Volunteers Start of enrollment: 2017 Aug 18
Completed
Phase 1
Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D Start of enrollment: 2019 Aug 22
Completed
Phase 2
Phase I Study of PH100 (Ecklonia Cava Phlorotannins) Start of enrollment: 2013 Sep 25
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

1 citations
Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens.
Jürgen B Bulitta, Edward Fang, Martin E Stryjewski, Wen Wang, George J Atiee
Antimicrobial Agents and Chemotherapy. 2024-04-03
A phase I, first-in-human study to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of MRG-001 in healthy subjects.
Ali R Ahmadi, George Atiee, Bart Chapman, Laurie Reynolds, John Sun
Cell Reports. Medicine. 2023-09-19
A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis.
Christine K Mauck, George J Atiee, Jennifer McCulloh, Laurie Reynolds, Nadene Zack
The Journal of Antimicrobial Chemotherapy. 2022-12-23

Press Mentions

Effective Study Design and Execution of Renal and Hepatic Impairment Trials, Upcoming Webinar Hosted by XtalksOctober 21st, 2024
Worldwide Clinical Trials Implements ClinSpark eSource PlatformOctober 17th, 2019
Worldwide Clinical Trials Expert to Present at Outsourcing in Clinical Trials West CoastFebruary 13th, 2017